Test Story with very long title, about Scientists with Public Health England said two shots of the Pfizer-BioNTech vaccine prevented hospital treatment in 96 per cent of cases, while the figure for two doses of the AstraZeneca-Oxford drug was 92 per cent.

Scientists with Public Health England said two shots of the Pfizer-BioNTech vaccine prevented hospital treatment in 96 per cent of cases, while the figure for two doses of the AstraZeneca-Oxford drug was 92 per cent.Scientists with Public Health England said two shots of the Pfizer-BioNTech vaccine prevented hospital treatment in 96 per cent of cases, while the figure for two doses of the AstraZeneca-Oxford drug was 92 per cent.Scientists with Public Health England said two shots of the Pfizer-BioNTech vaccine prevented hospital treatment in 96 per cent of cases, while the figure for two doses of the AstraZeneca-Oxford drug was 92 per cent.Scientists with Public Health England said two shots of the Pfizer-BioNTech vaccine prevented hospital treatment in 96 per cent of cases, while the figure for two doses of the AstraZeneca-Oxford drug was 92 per

cent.Scientists with Public Health England said two shots of the Pfizer-BioNTech vaccine prevented hospital treatment in 96 per cent of cases, while the figure for two doses of the AstraZeneca-Oxford drug was 92 per cent.Scientists with Public Health England said two shots of the Pfizer-BioNTech vaccine prevented hospital treatment in 96 per cent of cases, while the figure for two doses of the AstraZeneca-Oxford drug was 92 per cent.Scientists with Public Health England said two shots of the Pfizer-BioNTech vaccine prevented hospital treatment in 96 per cent of cases, while the figure for two doses of the AstraZeneca-Oxford drug was 92 per cent.Scientists with Public Health England said two shots of the Pfizer-BioNTech vaccine prevented hospital treatment in 96 per cent of cases, while the figure for two doses of the AstraZeneca-Oxford drug was 92 per cent.